Simplex Trading, LLC Graybug Vision, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$0.46 - $1.05 $436 - $996	-949 Reduced 98.24%	17 $0
Q3 2022 Nov 04, 2022	BUY	$0.93 - $1.18 $697 - $885	750 Added 347.22%	966 $0
Q2 2022 Aug 03, 2022	BUY	$0.76 - $1.25 $164 - $270	216 New	216 $0
Q1 2022 May 02, 2022	SELL	$1.13 - $1.93 $10,688 - $18,255	-9,459 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$1.74 - $3.6 $2,232 - $4,618	1,283 Added 15.69%	9,459 $17,000
Q2 2021 Aug 12, 2021	BUY	$3.53 - $6.1 $28,861 - $49,873	8,176 New	8,176 $44,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.